NHC executive granted 1,082 restricted shares

Dodson Vicki L reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/03/2026 - 05:09 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Dodson Vicki L reported acquisition or exercise transactions in this Form 4 filing.

National Healthcare Corp senior vice president Vicki L. Dodson received an equity award of 1,082 shares of common stock. The award was granted at no cash cost to her and increased her directly held common stock to 11,371.5455 shares.

The 1,082 shares are restricted stock that vest over three years. One-third is scheduled to vest on January 1, 2027, another third on January 1, 2028, and the final third on January 1, 2029, encouraging longer-term alignment with the company.

Insider Trade Summary

Grant/Award: 1,082 shares

Grant/Award 1 txn

Insider Dodson Vicki L

Role Sr.VP Patient Srvcs

Type	Security	Shares	Price	Value
Grant/Award	Shares of Common Stock held in my name	1,082	$0.00	$0.00
Holding	Option to Purchase Common Stock	--	--	--
Holding	Option to Purchase Common Stock	--	--	--
Holding	Option to Purchase Common Stock	--	--	--
Holding	Option to Purchase Common Stock	--	--	--

Holdings After Transaction: Shares of Common Stock held in my name — 11,371.5455 shares (Direct); Option to Purchase Common Stock — 39,234 contracts (Direct)

Footnotes (1)

1. F1. Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NHC executive Vicki Dodson report?

Vicki L. Dodson reported receiving an award of 1,082 shares of National Healthcare Corp common stock. The grant was made at no cash cost and increased her directly held common shares to 11,371.5455, reflecting routine equity compensation for her executive role.

How many NHC shares does Vicki Dodson own after this grant?

After the grant, Vicki L. Dodson directly holds 11,371.5455 shares of National Healthcare Corp common stock. This total includes the newly awarded 1,082 restricted shares that vest over time, alongside previously held shares already in her name.

What is the vesting schedule for Vicki Dodson’s 1,082 NHC restricted shares?

The 1,082 restricted shares vest in three equal installments over three years. One-third vests on January 1, 2027, the next third on January 1, 2028, and the final third on January 1, 2029, promoting longer-term retention and alignment.

Did Vicki Dodson buy or sell any NHC shares in this Form 4?

She did not report any open-market buys or sells. The Form 4 shows an acquisition of 1,082 shares through a grant or award, not a purchase, with no disposition transactions reported in the provided data for National Healthcare Corp stock.

What stock options holdings does Vicki Dodson report at NHC?

The Form 4 lists several “Option to Purchase Common Stock” lines showing post-transaction holdings of 3,734, 8,000, 13,500, and 14,000 options. These entries reflect option positions associated with National Healthcare Corp, reported as directly owned holdings, not new option exercises.

What role does Vicki Dodson hold at National Healthcare Corp (NHC)?

Vicki L. Dodson serves as Senior Vice President of Patient Services at National Healthcare Corp. The reported equity award of 1,082 restricted shares appears to be part of her executive compensation, aligning her interests with longer-term company performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dodson Vicki L

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TN 37130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Sr.VP Patient Srvcs

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Shares of Common Stock held in my name	02/27/2026		A		1,082(1)	A	$0	11,371.5455	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$53.94							03/08/2024	03/08/2028	Common Stock	3,734		3,734	D
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	8,000		8,000	D
Option to Purchase Common Stock	$90.62							02/24/2026	02/24/2030	Common Stock	13,500		13,500	D
Option to Purchase Common Stock	$157.13							02/23/2027	02/23/2031	Common Stock	14,000		14,000	D

Explanation of Responses:

1. Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029.

	/s/ Vicki L Dodson	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.